Orosz Szabolcs, Sarusi Annamária, Csík Norbert, Papp Julius Gy, Varró András, Farkas Sándor, Forster Tamás, Farkas Attila S, Farkas András
*Gedeon Richter Plc., Budapest, Hungary; †Department of Pharmacology and Pharmacotherapy, University of Szeged, Szeged, Hungary; ‡Department of Electrical Engineering and Cybernetics, Kecskemét College, Kecskemét, Hungary; §Division of Cardiovascular Pharmacology, Hungarian Academy of Sciences, Szeged, Hungary; and ¶Second Department of Medicine and Cardiology Centre, Faculty of Medicine, University of Szeged, Szeged, Hungary.
J Cardiovasc Pharmacol. 2014 Sep;64(3):266-76. doi: 10.1097/FJC.0000000000000116.
Isolated hearts with reduced repolarization reserve would be suitable for assessing the proarrhythmic liability of drugs. However, it is not known which proarrhythmia biomarkers indicate the increased susceptibility to torsades de pointes arrhythmia (TdP) in such experimental setting. Thus, we estimated the efficacy of proarrhythmia biomarkers in isolated hearts with attenuated repolarization reserve. Langendorff-perfused rabbit hearts were used. Repolarization reserve was reduced by concomitant inhibition of the rapid (IKr) and slow (IKs) delayed rectifier potassium currents by dofetilide and HMR-1556, respectively. Rate corrected QT (QTc) interval and beat-to-beat variability of the QT interval measured in sinus rhythm or irrespective of rhythm even during arrhythmias (sinus and absolute QT variability, respectively) were tested. QTc failed to predict increased proarrhythmic risk. Sinus QT variability indicated proarrhythmic liability when low concentration of dofetilide was used. However, when arrhythmias compromised sinus variability measurement during coperfusion of catecholamines and elevated concentration of dofetilide, only absolute QT variability indicated increased proarrhythmic risk. Absolute QT variability parameters seem to be the most practical and sensitive biomarkers of proarrhythmic liability in rabbit hearts with reduced repolarization reserve. Absolute QT variability parameters could serve as surrogates for torsades de pointes in drug-safety investigations in isolated rabbit hearts with attenuated repolarization reserve.
复极储备降低的离体心脏适合用于评估药物的致心律失常风险。然而,在这种实验环境下,尚不清楚哪些致心律失常生物标志物表明对尖端扭转型室性心动过速(TdP)的易感性增加。因此,我们评估了复极储备减弱的离体心脏中致心律失常生物标志物的效能。使用Langendorff灌注兔心脏。分别通过多非利特和HMR-1556同时抑制快速(IKr)和缓慢(IKs)延迟整流钾电流来降低复极储备。测试了在窦性心律下测量的心率校正QT(QTc)间期以及在心律失常期间(分别为窦性和绝对QT变异性)无论心律如何测量的QT间期逐搏变异性。QTc未能预测致心律失常风险增加。当使用低浓度多非利特时,窦性QT变异性表明有致心律失常风险。然而,当在儿茶酚胺共灌注和多非利特浓度升高期间心律失常影响窦性变异性测量时,只有绝对QT变异性表明致心律失常风险增加。绝对QT变异性参数似乎是复极储备降低的兔心脏中致心律失常风险最实用和敏感的生物标志物。在复极储备减弱的离体兔心脏的药物安全性研究中,绝对QT变异性参数可作为尖端扭转型室性心动过速的替代指标。